What Longeviti does

Longeviti Neuro Solutions, LLC is a privately held neurotechnology and medical device company founded in 2016 and headquartered in Baltimore, Maryland. The company develops and commercializes the ClearFit platform, a portfolio of FDA-cleared sonolucent cranial implants that allow ultrasound waves to pass through the skull, enabling real-time, radiation-free post-operative brain imaging at the bedside. Its product line includes ClearFit OTS (off-the-shelf sterilized implants in multiple shapes and curvatures), ClearFit Patient Specific (custom implants for cranial reconstruction), InvisiShunt, and InvisiLead (low-profile implants that accommodate neurosurgical hardware such as shunts while restoring skull contour). The company has also launched ClearFit AI, an AI-enabled imaging platform integrated with handheld ultrasound transducers from Clarius Mobile Health and GE Healthcare for point-of-care neurosurgical monitoring.

Longeviti serves a specialized neurosurgical end market — primarily neurosurgeons, neurointensivists, neuro-radiologists, and the hospitals and surgical centers where complex brain surgery is performed. Use cases include post-operative monitoring for hydrocephalus, tumor recurrence, hemorrhage, midline shift, EC-IC bypass patency, and pseudomeningocele, all of which historically require CT imaging, patient transport, and radiation exposure. The ClearFit platform addresses these pain points by enabling bedside ultrasound through the implant itself, reducing transport risk and radiation burden while supporting faster clinical decisions. The company has secured an ICD-10-PCS procedure code (XNR80D9) for the implant category, supporting hospital reimbursement.

The business operates an enterprise field-sales model targeting neurosurgery departments and hospitals, supported by a Sales Representative Portal for CT uploads and order placement, alongside medical education services (ClearFit Imaging Workflow training, neurosonography courses, phantom training, and site visits at Centers of Excellence). Revenue is generated primarily through one-time sales of the implants to hospitals, complemented by professional services revenue from training programs. The company has raised approximately $33.5M cumulatively across multiple SEC-exempt offerings (2019-2025), most recently receiving a $10M strategic capital infusion from Soleus Capital in August 2025. The board and leadership team includes former Stryker, K2M, and T. Rowe Price executives, and the company is led by CEO and co-founder Jesse Christopher with Dr. David Langer (Chair of Neurosurgery, Lenox Hill Hospital) as Chief Medical Officer.

Name

Longeviti

Legal name

Longeviti Neuro Solutions, LLC

Website

https://longeviti.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Longeviti Neuro Solutions is a Baltimore-based medical device company that develops and sells FDA-cleared sonolucent cranial implants (ClearFit platform) enabling real-time, radiation-free post-operative ultrasound brain imaging for neurosurgeons and hospitals performing complex brain surgery.

Ownership category

akta.pro rank

Product category

Neurosurgical Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)

akta.pro secondary industries

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)

Keywords

• Cranial implants
• Neurosurgical devices
• Sonolucent implants
• Post-operative imaging
• Brain surgery platforms

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales (Implants): Sale of FDA-cleared cranial implants including ClearFit OTS, ClearFit Patient Specific, InvisiShunt, and InvisiLead products. These are一次性医疗器械产品 sold to hospitals and surgical centers for neurosurgical procedures.
2. Medical Education Services: Provision of medical education including ClearFit imaging workflow training, neurosonography courses, phantom training, and site visits to Centers of Excellence. These services support clinical adoption and proper usage of ClearFit implants.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Longeviti designs, manufactures, and commercializes FDA-cleared sonolucent cranial implants under its ClearFit® platform, allowing real-time post-operative ultrasound imaging of the brain at the bedside without radiation exposure. The portfolio includes ClearFit OTS off-the-shelf implants, ClearFit Patient Specific custom implants, InvisiShunt and InvisiLead low-profile implants for neurosurgical device accommodation, and AI-powered handheld ultrasound transducers integrated with Clarius and GE systems.

Product overview

Longeviti Neuro Solutions is a neurotechnology company that has developed an innovative platform ecosystem for complex brain surgery. The core offering is the ClearFit® platform, which includes ClearFit® OTS (off-the-shelf) and ClearFit® Patient Specific cranial implants—sonolucent implants that enable real-time post-operative ultrasound imaging of the brain, eliminating the need for radiation-based imaging and enabling bedside monitoring. The platform also includes InvisiShunt® and InvisiLead, which are low-profile cranial implants that integrate seamlessly with the skull for neurosurgical device accommodation. The ClearFit AI™ component powers handheld ultrasound transducers from Clarius and GE, providing AI-enabled imaging capabilities. All products work together to provide comprehensive neurosurgical solutions that return patients to anatomical normalcy while providing functional neurotechnology.

Differentiator

Problem solved

Functional benefit

Brands

• ClearFit OTS: FDA-cleared off-the-shelf cranial implants that enable real-time ultrasound imaging at the bedside or clinic
• ClearFit Patient Specific
• InvisiShunt and InvisiLead
• ClearFit AI

Products and services

• ClearFit® OTS (Off-the-Shelf) Cranial Implants

Quantifiable outcome

• ICD-10-PCS Code: XNR80D9 assigned for Ultrasound Penetrable replacement cranial plate

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature4 records

Partnerships

Three partnerships are on record, tiered strategic.

• GE HealthcarestrategicTechnology or IntegrationGE Healthcare provides high-resolution, AI-enabled ultrasound systems that integrate with Longeviti's ClearFit platform, enabling real-time post-operative brain imaging through sonolucent cranial implants.
• Clarius Mobile HealthstrategicTechnology or IntegrationClarius provides wireless, high-resolution handheld ultrasound systems integrated with Longeviti's ClearFit AI platform for point-of-care brain imaging through cranial implants.
• Strategic Collaborators (Partners for Advancing Neurosurgery Technology)strategicStrategic or Co-development PartnerLongeviti partners with leading organizations to advance technology in neurosurgery. The company has a network of strategic collaborators including medical technology companies, healthcare institutions, and research organizations (specific partners listed via logos on About page).

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Integra LifeSciences: Integra LifeSciences is a leading neurosurgical and CMF (craniomaxillofacial) implant manufacturer with overlapping cranial plate, dural repair, and neurosurgery portfolios, making it the closest direct competitor to Longeviti in cranial reconstruction hardware.
• KLS Martin: KLS Martin specializes in CMF surgery implants and distraction devices, directly comparable to Longeviti's patient-specific cranial implant offering, particularly in reconstructive and trauma cranial procedures.

Broad incumbents

• Stryker: Stryker operates one of the largest neurosurgery, spine, and CMF businesses globally, including cranial implants and instrumentation, and Longeviti's Chair Tim Scannell is the former Stryker President & COO, indicating direct overlap in neurosurgical implant categories.
• DePuy Synthes (Johnson & Johnson): DePuy Synthes is the dominant CMF and neurosurgical implant franchise within J&J MedTech, offering cranial plates, fixation, and neurosurgical tools that compete head-to-head with Longeviti's ClearFit and InvisiShunt implants in hospital tenders.
• Medtronic: Medtronic's Neurosurgery business includes shunts and cranial fixation products that overlap with Longeviti's InvisiShunt and ClearFit offerings, and the company competes with Longeviti in the same neurosurgery hospital call points.
• Aesculap (B. Braun): Aesculap, the surgical division of B. Braun, offers CMF implants and neurosurgical instrumentation, competing with Longeviti across cranial reconstruction and neurosurgical workflows in hospitals globally.
• Penumbra: Penumbra is a neurovascular and neurosurgery-focused medical device company with overlapping presence in neurosurgical hospital accounts and adjacent technology to Longeviti's neuro-implant and AI workflow platform.

Emerging players

• Hyperfine: Hyperfine makes the FDA-cleared Swoop portable MRI for point-of-care brain imaging at the bedside, an emerging alternative imaging modality to Longeviti's ClearFit ultrasound-based bedside monitoring in neuro-ICU and post-operative settings.
• NovaSignal: NovaSignal develops AI-enabled transcranial Doppler ultrasound for automated brain blood flow assessment, overlapping with Longeviti's ClearFit AI platform in point-of-care neurovascular imaging through the skull.
• Viz.ai: Viz.ai applies AI to neuroimaging workflows for stroke and other neurological conditions, overlapping with Longeviti's ClearFit AI strategy of embedding software intelligence into neurosurgical and neuro-imaging workflows.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/longeviti
• Facebookfacebook.com/longevitineurosolutions
• LinkedInlinkedin.com/company/longeviti
• Instagraminstagram.com/longeviti_neurosolutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds9 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Longeviti